Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,312 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

A Study of LY3015014 in Participants With High Cholesterol

NCT01890967

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Encino, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lancaster, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spring Valley, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
View all 49 locations
View Trial Details
Completed

Primary Prevention Program

NCT03927196

Conditions
Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +3 more
Locations
  • Deputy Chief Medical Officer for Prevention at the Center for Medical Prevention Astrakhan, Russia
  • Nizhny Novgorod Regional Center for Medical Prevention Nizhny Novgorod, Russia
  • Regional Center for Medical Prevention Novosibirsk, Russia
  • Samara Regional Center for Medical Prevention Samara, Russia
View Trial Details
Completed

Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

NCT02984982

Conditions
Acute Coronary Syndrome, Cardiovascular Diseases, Dyslipidemias, +8 more
Locations
  • Investigational Site Number 392026 Bunkyō City, Japan
  • Investigational Site Number 392022 Chiyoda-ku, Japan
  • Investigational Site Number 392032 Fujisawa-shi, Japan
  • Investigational Site Number 392004 Fukui-shi, Japan
View all 39 locations
View Trial Details
Completed

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

NCT03415178

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 8400024 Los Angeles, California, United States
  • Investigational Site Number 8400007 Jacksonville, Florida, United States
  • Investigational Site Number 8400017 Jacksonville, Florida, United States
  • Investigational Site Number 8400013 Ponte Vedra, Florida, United States
View all 13 locations
View Trial Details
Completed

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

NCT02890992

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 8400002 St Louis, Missouri, United States
  • Investigational Site Number 8400005 Charlotte, North Carolina, United States
  • Investigational Site Number 8400001 Cincinnati, Ohio, United States
  • Investigational Site Number 1240001 Québec, Canada
View all 16 locations
View Trial Details

Related conditions